fda status bpc-157 approval RFK Jr pushes for of peptide | Eric Topol, MD posted on the topic fda approval status bpc-157 tb-500

Bergami M, Santi S, Formaggio E, Cagnoli C, Verderio C, Blum R, Berninger B, Matteoli M, Canossa M

[41:17] Special Populations: Strokes, Aneurysms, and the 'Pop' Theory [46:15] The Pelvic Floor: Stress Incontinence and the Weightlifter's Paradox [49:34] Pregnancy: Monitoring Fetal Heart Rates During Heavy Braced Lifting [56:42] Contraindications: When is the Valsalva Maneuver Actually Dangerous

Using the free base can lead to non-uniform suspensions, inaccurate dosing, and lower-than-expected plasma concentrations, directly compromising the integrity of pharmacokinetic and pharmacodynamic studies that rely on the published clinical trial data established with the phosphate form

Studies show that NNMT inhibition by 5-amino-1-methylquinolinium significantly reduces nicotinamide metabolism, increases NAM accumulation, improves NAD+ synthesis efficiency by over 30%, and markedly increases mitochondrial ATP production and cellular energy metabolism